Cerba Oncology provides an array of innovative analyses of over 50 assays and tests, specifically consisting of 600 genes of interest in oncosomatics and oncogenetics and supports you in selecting your analyses.
Today, precision genomic medicine offers new therapeutic solutions that need to be usable and accessible.
To achieve this, it is crucial to bring together : our expertise , complex knowledge, experts in the field, innovative and high-performance tools.
